A61K 38/366
Thrombomodulin
Official title: {Thrombomodulin}
A61K38/366 (Thrombomodulin) appears on 37 US grants and 63 published applications in this corpus.
Search patents in A61K- Granted patents
- 37
- Published applications
- 63
- Assignees
- 29
- Inventors
- 103
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 4 |
| 2007 | 3 | 2 |
| 2008 | 0 | 0 |
| 2009 | 2 | 4 |
| 2010 | 4 | 3 |
| 2011 | 0 | 5 |
| 2012 | 2 | 2 |
| 2013 | 1 | 3 |
| 2014 | 1 | 4 |
| 2015 | 3 | 4 |
| 2016 | 0 | 1 |
| 2017 | 5 | 3 |
| 2018 | 0 | 2 |
| 2019 | 2 | 2 |
| 2020 | 1 | 5 |
| 2021 | 1 | 3 |
| 2022 | 4 | 2 |
| 2023 | 2 | 4 |
| 2024 | 1 | 4 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Medicament for therapeutic treatment and/or improvement of sepsis accompanied by coagulopathy6 Jan 2026US 12,514,910 B2Asahi Kasei Pharma Corporation
- Microvascular blood flow decreasing agent and use thereof29 Jul 2025US 12,370,239 B2
- Low concentrated protein compositions for preventing tissue adhesion5 Mar 2024US 11,918,629 B2Omrix Biopharmaceuticals Ltd.
- Fusion proteins and antibodies targeting human red blood cell antigens18 Apr 2023US 11,629,198 B2The Trustees of the University of Pennsylvania
- High concentrated protein compositions for preventing tissue adhesion21 Feb 2023US 11,583,573 B2Omrix Biopharmaceuticals Ltd.
- Freeze-dried plasma (fdp) for well-balanced coagulation and fibrinolysis, method of preparation and use thereof9 Jul 2026US 2026/0191903 A1Army Medical University, People's Liberation Army, Prc
- Thrombomodulin protein and mirna for preventing or treating osteoathritis13 Nov 2025US 2025/0345399 A1Kaohsiung Medical University
- Biomarkers to detect risk of sinusoidal obstruction syndrome24 Oct 2024US 2024/0353424 A1MUSC Foundation for Research Development
- Compositions and methods for treating hair loss or facilitating hair growth15 Aug 2024US 2024/0269240 A1Blue Blood Biotech Corp.
- Methods of using glycopolysialylated therapeutic proteins15 Aug 2024US 2024/0269300 A1Xenetic Biosciences, Inc.
Most cited
By later US patents
- Method for treating liver injury16US 5,916,874 AAsahi Kasei Kogyo Kabushiki Kaisha · 1999
- Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases14US 7,501,114 B2Biovec, LLC · 2009
- Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI14US 8,546,096 B2Baxter Healthcare S. A. · 2013
- Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases12US 7,179,459 B2Biovec, LLC · 2007
- Medicament for therapeutic treatment and/or improvement of sepsis9US 8,772,239 B2Asahi Kasei Pharma Corporation · 2014